Skip to content

Author

N. de Prost

We have 2 of 446 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Detection of a Nirsevimab-Resistant RSV-B Variant (F:K68Q) in an Adult with Severe Infection

F:K68Q appears to be rare among circulating RSV-B strains based on available global sequence surveillance data (GISAID), and its detection in a monoclonal antibody-naïve patient reinforces the hypothesis that this substitution may circulate independently of nirsevimab exposure.

N. de Prost, M. Le Goff, P. Cappy et al. · 0 citations
Jul 2026

Complement augments antibody neutralization of SARS-CoV-2 variants.

The data show that complement potentiates the ability of antispike antibodies to neutralize immune-evasive SARS-CoV-2 variants and in sera from individuals with severe COVID-19, both complement-mediated neutralization and anti-S2 antibody levels were associated with improved survival.

M. Jungbauer-Groznica, Pierre Rosenbaum, I. Staropoli et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.